These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15173094)

  • 21. Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341.
    Fang Y; Hu Y; Wu P; Wang B; Tian Y; Xia X; Zhang Q; Chen T; Jiang X; Ma Q; Xu G; Wang S; Zhou J; Ma D; Meng L
    Cancer Invest; 2011 May; 29(4):247-52. PubMed ID: 21345073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
    Yu C; Friday BB; Lai JP; McCollum A; Atadja P; Roberts LR; Adjei AA
    Clin Cancer Res; 2007 Feb; 13(4):1140-8. PubMed ID: 17317822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
    Dai Y; Chen S; Kramer LB; Funk VL; Dent P; Grant S
    Clin Cancer Res; 2008 Jan; 14(2):549-58. PubMed ID: 18223231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma.
    Kobayashi Y; Ohtsuki M; Murakami T; Kobayashi T; Sutheesophon K; Kitayama H; Kano Y; Kusano E; Nakagawa H; Furukawa Y
    Oncogene; 2006 Jan; 25(4):512-24. PubMed ID: 16186804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.
    Zhang Y; Adachi M; Zou H; Hareyama M; Imai K; Shinomura Y
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):859-66. PubMed ID: 16751067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo.
    Sawa H; Murakami H; Kumagai M; Nakasato M; Yamauchi S; Matsuyama N; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
    Acta Neuropathol; 2004 Jun; 107(6):523-31. PubMed ID: 15024582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).
    Sutheesophon K; Nishimura N; Kobayashi Y; Furukawa Y; Kawano M; Itoh K; Kano Y; Ishii H; Furukawa Y
    J Cell Physiol; 2005 May; 203(2):387-97. PubMed ID: 15515013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
    Vinodhkumar R; Song YS; Devaki T
    Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.
    Kawano T; Horiguchi-Yamada J; Iwase S; Akiyama M; Furukawa Y; Kan Y; Yamada H
    Anticancer Res; 2004; 24(5A):2705-12. PubMed ID: 15517875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation.
    Savickiene J; Treigyte G; Borutinskaite V; Navakauskiene R; Magnusson KE
    Ann N Y Acad Sci; 2006 Dec; 1091():368-84. PubMed ID: 17341629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis.
    Drexler HC; Euler M
    Apoptosis; 2005 Aug; 10(4):743-58. PubMed ID: 16133866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proteasome inhibitor PS-341 in cancer therapy.
    Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
    Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
    Emanuele S; Lauricella M; Carlisi D; Vassallo B; D'Anneo A; Di Fazio P; Vento R; Tesoriere G
    Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.
    Nishida K; Komiyama T; Miyazawa S; Shen ZN; Furumatsu T; Doi H; Yoshida A; Yamana J; Yamamura M; Ninomiya Y; Inoue H; Asahara H
    Arthritis Rheum; 2004 Oct; 50(10):3365-76. PubMed ID: 15476220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
    Nawrocki ST; Carew JS; Pino MS; Highshaw RA; Andtbacka RH; Dunner K; Pal A; Bornmann WG; Chiao PJ; Huang P; Xiong H; Abbruzzese JL; McConkey DJ
    Cancer Res; 2006 Apr; 66(7):3773-81. PubMed ID: 16585204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
    Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells.
    Kang J; Zhang D; Chen J; Liu Q; Lin C
    Toxicol In Vitro; 2005 Mar; 19(2):173-82. PubMed ID: 15649630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.
    Chen G; Li A; Zhao M; Gao Y; Zhou T; Xu Y; Du Z; Zhang X; Yu X
    J Proteome Res; 2008 Jul; 7(7):2733-42. PubMed ID: 18549279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
    Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.